Narnolia

Narnolia

Toll Free No: 1800-103-7212

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE414.708.6 (+2.12 %)
PREV CLOSE ( ) 406.10
OPEN PRICE ( ) 403.00
BID PRICE (QTY) 414.50 (78)
OFFER PRICE (QTY) 414.75 (25)
VOLUME 414728
TODAY'S LOW / HIGH ( )400.45 420.35
52 WK LOW / HIGH ( )211.3 410.35
NSE414.158.2 (+2.02 %)
PREV CLOSE( ) 405.95
OPEN PRICE ( ) 400.50
BID PRICE (QTY) 414.15 (272)
OFFER PRICE (QTY) 414.25 (256)
VOLUME 6696618
TODAY'S LOW / HIGH( ) 400.50 420.50
52 WK LOW / HIGH ( )211.05 410.45
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 29-11 1978
Management Info
Kiran Muzumdar Shaw - Chairman Siddharth Mittal - Managing Director
Registered Office

Address 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone 080 2808 2808

Email corporate.communications@biocon.com

Website www.biocon.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
03Jul Biocon to invest Rs 1,500 crore on cap
Biocon is expecting to invest $200 million (around Rs 1,500 crore) on ca..
22Jun Biocon’s arm, DKSH collaborate to comm
Biocon’s subsidiary--Biocon Pharma and DKSH Business Unit Healthcare, ha..
22Jun Biocon informs about press release
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure..
22Jun Biocon surges as its arm collaborates
Biocon is currently trading at Rs. 387.50, up by 6.00 points or 1.57% fr..
12Jun Biocon, Wipro and Lupin to see some ac
Biocon and Mylan N.V. have received an approval from the US Food and Dru..
Financials
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit10224409
Gross Profit 1085 5482
Operating Profit 11064877
Net Sales 482419884
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Solara Active Pharma (BSE)
peergroup  670.00 (5.29%)
M.Cap ( in Cr)1808.70
Torrent Pharma (BSE)
peergroup  2396.10 (1.39%)
M.Cap ( in Cr)40693.85
Themis Medicare (BSE)
peergroup  397.00 (7.09%)
M.Cap ( in Cr)364.76
Dr. Reddys Lab (BSE)
peergroup  3921.95 (0.66%)
M.Cap ( in Cr)65329.38
Divis Lab (BSE)
peergroup  2200.55 (1.14%)
M.Cap ( in Cr)58442.91
Shareholding Pattern
PROMOTERS 60.67%
MUTUAL FUNDS/UTI 5.13%
NON-INSTITUTION 17.03%
FI/BANKS/INSURANCE 1.62%
GOVERNMENT 0%
FII 0%
About Biocon Ltd.

Biocon Ltd. was incorporated in the year 1978. Its today's share price is 406.1. Its current market capitalisation stands at Rs 49794 Cr. In the latest quarter, company has reported Gross Sales of Rs. 63672 Cr and Total Income of Rs.68747 Cr. The company's management includes Bobby Parikh, M Damodaran, Vijay Kumar Kuchroo, Daniel M Bradbury, Mary Harney, Ravi Mazumdar, Siddharth Mittal, John Shaw, Kiran Muzumdar Shaw.

It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

Directory

current IPO
  • --
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room